NCT01388127

Unknown

Minocycline Treatment in Acute Hemorrhagic Stroke

Wolfson Medical Center Source

Other study identifiers

Sponsor study identifier

0048-11 WOMC

Study Type

observational

Estimated enrollment

150

Locations

1 country

Sites

1

Timeline

Study Start

July 2011

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

July 2012

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

July 2012

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

The investigators will perform a double blind controlled study to investigate the efficacy of oral administration of 200 mg minocycline, on the neurological and functional outcome after acute hemorrhagic stroke and the effect on blood brain barrier permeability.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 150 participants
Study completion date: July 2012
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
July 2011
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
July 3, 2011
Actual (reported)
First Posted
July 6, 2011
Actual (reported)
Primary Completion
July 2012
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2012
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: July 6, 2011
Status Verified: June 2011
Last Update Submitted: July 5, 2011

Conditions

Poor Performance Status

Eligibility Criteria

Age18 Years - 90 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

150 patients after acute hemorrhagic stroke. Half treated with Minocycline.

You may qualify if:

Patients with acute hemorrhagic stroke
age \> 18
NIHSS score \> 5
onset of stroke 6 to 24 hours prior to beginning of treatment. Patients, who arrived within 0 to 6 hours post stroke, were treated with other medications according to the best accepted medical treatment guidelines.

You may not qualify if:

Sponsors & Collaborators

Wolfson Medical Center
Governmentlead

Study Sites (1)

Edith Wolfson Medical Center

Holon, Israel, 58100, Israel

Yair Lampl, MDCONTACT972-3-5028512 ext. 8512 y_lampl@hotmail.com

Yair Lampl, MDPRINCIPAL INVESTIGATOR

Study Officials

Yair Lampl, MD
Edith Wolfson Medical Center
PRINCIPAL INVESTIGATOR

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER GOV

Study Record Dates

First Submitted

July 3, 2011

First Posted

July 6, 2011

Study Start

July 2011

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

July 2012

Estimated (date passed)

NCT02332083

Innovative Training Program for Elderly in Need of Care

Not ApplicableCompleted

NCT05826483

Almonertinib in the First-line Treatment of Patients of NSCLC With Poor Performance Status

Phase 1Unknown

NCT01882335

Saving Brain in Uganda and Burkina Faso

Not ApplicableUnknown

Evidence of other disease of the central nervous system, including brain tumor, demyelinating disease, inflammatory disease of the central nervous system, craniotomy in the past, severe brain injuries and benign intracranial hypertension

pre-existing neurological disability

known allergic response to tetracyclines

acute or chronic renal failure

pre-existing infectious disease requiring antibiotic therapy

swallowing difficulties

Contact the study team to confirm eligibility.

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

July 2012

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

July 6, 2011

Record last verified: 2011-06

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01388127
Data provider: ClinicalTrials.gov
Source updated: 2011-07-06
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:32:06 UTC

Locations

IL(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Study Design

Study Record Dates

Source record

Locations